Clinical trial
A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the…
NCT00350467 · Xian-Janssen Pharmaceutical Ltd., Industry · Completed
Key facts
| NCT number | NCT00350467 |
|---|---|
| Title | A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia |
| Official title | A Randomized, 6-week Double-blind, Parallel Study to Evaluate the Efficacy and the Safety of Flexible Doses of Extended Release OROS Paliperidone Compared With Olanzapine in the Treatment of Patients With Schizophrenia |
| Lead sponsor | Xian-Janssen Pharmaceutical Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Schizophrenia |
| Intervention type | Drug |
| Interventions | ER OROS paliperidone and Olanzapine |
| Enrollment | 288 |
| Start date | Jun 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Jul 10, 2006 |
| Last update posted | May 19, 2011 |
| Countries | China |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: